Navigation Links
BiPar Sciences Expands Clinical Program for BSI-201, a Novel DNA Repair Inhibitor, in Brain Cancer
Date:4/10/2008

he standard treatment of GBM makes this a promising study," said BiPar Executive Vice President Barry Sherman, M.D. "It is the promise of this approach that encouraged the leaders of NABTT to evaluate BSI-201 in patients with GBM."

GBM is an aggressive form of brain cancer that strikes 10,000 patients a year in the United States. Currently, patients are often treated with radiotherapy and chemotherapy where the median survival is under 15 months. The initial study phase will evaluate the safety and tolerability of BSI-201 in combination with temozolomide given at standard doses. The Phase 2 component will assess BSI-201 combined with temozolomide plus radiation therapy in newly diagnosed GBM patients, where the primary endpoint is overall survival.

Additional Data to be Presented at Upcoming AACR 2008 Meeting

BiPar will present preclinical data on BSI-201 at the American Association for Cancer Research (AACR) Annual Meeting in San Diego on Monday, April 14, 2008. The abstract, "Activity of BSI-201, a potent poly (ADP-ribose) polymerase (PARP) inhibitor, alone and in combination with topotecan in human ovarian xenografts," will be presented at 8 a.m. in the "New Agents and Therapeutic Approaches" session.

About BiPar Sciences

BiPar Sciences is a drug development company with a therapeutic focus on novel mechanisms of action in oncology. Our existing platform is based on DNA repair, specifically with poly ADP-ribose polymerase (PARP) inhibitors. BSI-201 is the lead PARP inhibitor program in Phase 2 clinical trials in multiple solid tumor settings.


'/>"/>
SOURCE BiPar Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine technology :

1. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
2. BiPar Announces Preclinical Data Demonstrating Anti-Tumor Activity With BSI-401, Its Second-Generation PARP Inhibitor
3. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
4. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
8. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
9. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/9/2008)...RNewswire-FirstCall/ -- Diamyd Medical reports,tha...e New England Journal,of Medicine, has published a... the Diamyd(R) diabetes vaccine for type 1 diabete...0080314/297194 ), The article is now available o...nd will be in print on October 30. It presents the...
(Date:10/8/2008)...Animal Use in Cosmetics and Chemicals Testing, AS...today announced,that results of a recently complet...idation study on MatTek,s EpiDerm in vitro human s...ed the required sensitivity and,specificity for Ep... animal,testing for determining human skin irritat...
(Date:10/8/2008)... Pioneers Research That May Offer New Hope to,Hear...-- Nationally, over 3,000 people are,waiting for a..., only half,of those will receive a transplant. No...(AHI) is paving the way for how to treat congestiv...imedia News Release, go to:, http://www.prnewswire...
(Date:10/8/2008)...od Scientists Expand Testing Using Cellular ...AND, Maine, Oct. 8 /- Wild Blueberry ...se of results from a new study,showing Wild Bluebe...,fruits like apples, bananas, red grapes and straw...ioxidant Activity (CAA) assay. New research,publis...
Breaking Medicine Technology:Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Mayo Clinic study points to a possible biomarker for colon cancer in people 50 and under 4772 1Mayo Clinic study points to a possible biomarker for colon cancer in people 50 and under 4772 2IBA and Elekta Initiate Global Particle Therapy Program at ASTRO 684 1IBA and Elekta Initiate Global Particle Therapy Program at ASTRO 684 2IBA and Elekta Initiate Global Particle Therapy Program at ASTRO 684 3American Red Cross Blood Services Supports Blood Needs of Southern California 4764 1American Red Cross Blood Services Supports Blood Needs of Southern California 4764 2UD researchers race ahead with latest spintronics achievement 1543 1UD researchers race ahead with latest spintronics achievement 1543 2
...IRE)--Jul 2, 2007 - Tercica, Inc.,(NASDAQ:TRCA) to...,investment community presentation at the C.E. Unt...rence at the Mandarin Oriental,Hotel in New York o...me (1:00 p.m. Pacific time)., A live audio webcast...Internet by visiting the Investors section of the ...
...IRE)--Jul 2, 2007 - ViaCell, Inc.,(NASDAQ: VIAC) t...ief Executive Officer of ViaCell, will present an ...line at the C.E. Unterberg,Towbin Emerging Growth...7 at 3:00 p.m. at the Mandarin Oriental Hotel in N...ion will be available on,the Investor Information ...
Other Medicine Technology:
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...cials for junk foods at an alarming rate, says a n...r Family Foundation found that children between 8 ...ls - an average of 21 a day or more than 7,600 per...s, teens viewed approximately 17 food advertisemen...
...d even scientists. It is only one of the few organ...tissue. This process of regeneration may be simple...he Journal of Biological chemistry, has enabled no...lls, the way they regenerate, which could have imp...
...arolina mulled over the dangerous life-threatening...und out that the rhythmic motion of the lungs is v... from the lungs. The research published in the la...y could change existing treatment methods for cyst...
..., UN-Habitat and cola giant Coca Cola signed a thr...ccess to safe drinking water and improved sanitati...00. The project in India will be implemented in W... in association with local non-government organisa...
Other Medicine News:Health News:Liver Regeneration Unplugged 2Health News:Campaign for Safe Drinking Water in India, Nepal 2
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: